Vericel Corporation Logo
Vericel to Host Second-Quarter 2015 Earnings Webcast and Conference Call on August 12, 2015
July 29, 2015 08:30 ET | Vericel Corporation
CAMBRIDGE, Mass., July 29, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel Announces Plan to Submit HDE Supplement to the FDA to Revise the Labeled Indications for Use and Add Pediatric Labeling for Epicel
July 14, 2015 08:00 ET | Vericel Corporation
CAMBRIDGE, Mass., July 14, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel Announces Plan to Submit Biologics License Application to FDA by Year-End 2015 for MACI for the Treatment of Cartilage Defects in the Knee
June 10, 2015 07:00 ET | Vericel Corporation
CAMBRIDGE, Mass., June 10, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel Reports First-Quarter 2015 Financial Results
May 14, 2015 16:05 ET | Vericel Corporation
Total Revenues of $10.8 Million Reported for the First Quarter Conference Call Today at 4:30pm Eastern Time CAMBRIDGE, Mass., May 14, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation...
Vericel Corporation Logo
Vericel to Host First-Quarter 2015 Earnings Webcast and Conference Call on May 14, 2015
April 30, 2015 08:00 ET | Vericel Corporation
CAMBRIDGE, Mass., April 30, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel to Present at Needham Healthcare Conference
April 08, 2015 16:01 ET | Vericel Corporation
CAMBRIDGE, Mass., April 8, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel Reports Three-Year Follow-Up Results From Phase 3 SUMMIT Extension Study of MACI(TM) Implant
March 25, 2015 07:30 ET | Vericel Corporation
CAMBRIDGE, Mass., March 25, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel Reports Fourth-Quarter and Year-End 2014 Financial Results
March 23, 2015 16:01 ET | Vericel Corporation
Total Revenues of $14.7 Million Reported for the Fourth Quarter Conference Call Today at 4:30pm Eastern Time CAMBRIDGE, Mass., March 23, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation...
Vericel Corporation Logo
Vericel to Present at Canaccord Genuity and ARM Investor Conferences
March 18, 2015 08:51 ET | Vericel Corporation
CAMBRIDGE, Mass., March 18, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...
Vericel Corporation Logo
Vericel to Host Fourth-Quarter 2014 Earnings Call on March 23, 2015
March 12, 2015 16:30 ET | Vericel Corporation
CAMBRIDGE, Mass., March 12, 2015 (GLOBE NEWSWIRE) -- Vericel Corporation (Nasdaq:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and...